Ensuring access to working antimicrobials – Parliament [UK] Commons Select Committee [Science and Technology] – 7 July 2014

Posted on July 11, 2014. Filed under: Infectious Diseases, Pharmacy | Tags: , |

Ensuring access to working antimicrobials – Parliament [UK] Commons Select Committee [Science and Technology] – 7 July 2014

Report

“Ministers must stop unnecessary use of antibiotics in healthcare and farming

The Government’s announcement of a review of the economics of antimicrobial research is a welcome step in addressing one aspect of antimicrobial resistance. However, current practice across both health and veterinary services is failing to prevent the inappropriate prescription of antibiotics. The Government needs to set clear responsibilities at all levels of the NHS and veterinary medicine to achieve better stewardship of the antimicrobial drugs vital in modern medicine, the Science and Technology Committee has warned.”

… continues on the site

 

Advertisements
Read Full Post | Make a Comment ( Comments Off on Ensuring access to working antimicrobials – Parliament [UK] Commons Select Committee [Science and Technology] – 7 July 2014 )

UK 5 Year Antimicrobial Resistance (AMR) Strategy – Measuring Success – 23 June 2014

Posted on June 24, 2014. Filed under: Infectious Diseases | Tags: |

UK 5 Year Antimicrobial Resistance (AMR) Strategy – Measuring Success – 23 June 2014

“Antimicrobial resistance is when infections caused by microorganisms survive exposure to a drug that was supposed to kill them or stop their growth, this is a particular problem with antibiotics.

The measures agreed by the UK antimicrobial resistance strategy High Level Steering Group, taking advice from expert scientific advisory committees including the Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infections (ARHAI), cover 4 areas:

trends in resistance
quality of prescribing in primary and secondary healthcare settings
public and professional knowledge and understanding of antimicrobials and their appropriate use.
global security through ensuring global alignment in addressing AMR

These measures apply equally to human and animal health.”

Antimicrobial Resistance (AMR): information and resources

 

Read Full Post | Make a Comment ( Comments Off on UK 5 Year Antimicrobial Resistance (AMR) Strategy – Measuring Success – 23 June 2014 )

Final Opinion on Nanosilver: safety, health and environmental effects and role in antimicrobial resistance – European Commission – 13 June 2014

Posted on June 17, 2014. Filed under: Infection Control, Infectious Diseases | Tags: |

Final Opinion on Nanosilver: safety, health and environmental effects and role in antimicrobial resistance – European Commission – 13 June 2014

“Today, the European Commission and its non-food Scientific Committee on Emerging and Newly Identified Health Risks, SCENIHR, published the final opinion on “Nanosilver: safety, health and environmental effects and role in antimicrobial resistance”.

The aim of this opinion is to assess whether the use of nanosilver, in particular in medical care and in consumer products, could result in additional risks compared to more traditional uses of silver and whether the use of nanosilver to control bacterial growth could result in resistance of micro-organisms.

SCENIHR concludes that the widespread (and increasing) use of silver containing products implicates that both consumers and the environment are exposed to new sources of silver. Human exposure is direct (food, hand-to-mouth contact, skin) and may be life long; while in the environment silver nanoparticles may be a particularly effective delivery system for silver to organisms in soil, water and sediment and may act as sources of ionic silver over extended periods of time. Therefore, additional effects caused by widespread and long term use of silver nanoparticles cannot be ruled out.

Regarding the hazard associated with the dissemination of the resistance mechanism following the use of silver nanoparticles, more data are needed to better understand bacterial response to ionic silver and silver nanoparticles exposure.”

 

Read Full Post | Make a Comment ( Comments Off on Final Opinion on Nanosilver: safety, health and environmental effects and role in antimicrobial resistance – European Commission – 13 June 2014 )

Enterococci: From Commensals to Leading Causes of Drug Resistant Infection – eBook, NCBI – 2014

Posted on March 25, 2014. Filed under: Infection Control | Tags: |

Enterococci: From Commensals to Leading Causes of Drug Resistant Infection – eBook, NCBI – 2014

“Over the past 30 years, multidrug resistant enterococci have emerged as leading causes of hospital acquired infection. With the acquisition of resistance to vancomycin in the mid 1980’s many of these infections became extremely difficult to treat. To address this problem, researchers with an interest in various aspects of enterococcal biology have come together to consolidate much of what is known about this genus into a single text. Enterococci: From commensals to leading causes of drug resistant infection provides state-of-the-art summaries of what is known about 1) Their origins, distribution in nature and gut colonization, 2) Infection – history, incidence, and pathology, 3) Enterococci as indicators of contamination and in public policy, 4) Infection treatment and antibiotic resistance, 5) Pathogenesis and models of enterococcal infection, 6) Comparative enterococcal genomics, 7) Nature, maintenance and transmission of extrachromosomal elements, 8) Enterococcal phage and genome defense, 9) Transcriptional and post transcriptional control of enterococcal gene regulation, 10) Enterococcal cell wall components and structures, 11) Enterococcal biofilm structure and role in colonization and disease, 12) Metabolic and physiologic traits that contribute to the special biology of enterococci, and 13) Enterococcal bacteriocins and other bacterial factors that contribute to niche control.”

 

 

Read Full Post | Make a Comment ( Comments Off on Enterococci: From Commensals to Leading Causes of Drug Resistant Infection – eBook, NCBI – 2014 )

Antibiotic resistance threats in the United States, 2013 – CDC – 16 September 2013

Posted on September 17, 2013. Filed under: Infection Control, Infectious Diseases | Tags: , , |

Antibiotic resistance threats in the United States, 2013 – CDC – 16 September 2013

“This report, Antibiotic resistance threats in the United States, 2013 gives a first-ever snapshot of the burden and threats posed by the antibiotic-resistant germs having the most impact on human health.

Each year in the United States, at least 2 million people become infected with bacteria that are resistant to antibiotics and at least 23,000 people die each year as a direct result of these infections. Many more people die from other conditions that were complicated by an antibiotic-resistant infection.

Antibiotic-resistant infections can happen anywhere. Data show that most happen in the general community; however, most deaths related to antibiotic resistance happen in healthcare settings such as hospitals and nursing homes.”

Press release: Untreatable: Report by CDC details today’s drug-resistant health threats Landmark report ranks threats, outlines four core actions to halt resistance

Digital Press Kit: Untreatable: Today’s Drug-Resistant Health Threats

Read Full Post | Make a Comment ( Comments Off on Antibiotic resistance threats in the United States, 2013 – CDC – 16 September 2013 )

UK 5 Year Antimicrobial Resistance Strategy 2013 to 2018 – 10 September 2013

Posted on September 12, 2013. Filed under: Infectious Diseases, National Health Strategies | Tags: |

UK 5 Year Antimicrobial Resistance Strategy 2013 to 2018 – 10 September 2013

Press release

Read Full Post | Make a Comment ( Comments Off on UK 5 Year Antimicrobial Resistance Strategy 2013 to 2018 – 10 September 2013 )

The evolving threat of antimicrobial resistance – options for action – World Health Organization – 8 March 2012

Posted on March 9, 2012. Filed under: Infectious Diseases, Pharmacy | Tags: , |

The evolving threat of antimicrobial resistance – options for action – World Health Organization – 8 March 2012

ISBN 978 92 4 150318 1

“This publication has been produced by the WHO Patient Safety Programme as part of its solid commitment to promoting safer care worldwide. It is the result of an international consultation process started in 2008, which gathered input from over 50 international experts in the field of antimicrobial resistance.”

Read Full Post | Make a Comment ( Comments Off on The evolving threat of antimicrobial resistance – options for action – World Health Organization – 8 March 2012 )

Liked it here?
Why not try sites on the blogroll...